Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors
- 1 April 2007
- journal article
- Published by Elsevier in Matrix Biology
- Vol. 26 (3) , 175-184
- https://doi.org/10.1016/j.matbio.2006.10.012
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Structural and Functional Mutations of the Perlecan Gene Cause Schwartz-Jampel Syndrome, with Myotonic Myopathy and ChondrodysplasiaAmerican Journal of Human Genetics, 2002
- Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan geneNature Genetics, 2001
- Mapping Ligand Binding Domains in Chimeric Fibroblast Growth Factor Receptor MoleculesJournal of Biological Chemistry, 1999
- Perlecan is essential for cartilage and cephalic developmentNature Genetics, 1999
- Characterization of Recombinant Perlecan Domain I and Its Substitution by Glycosaminoglycans and OligosaccharidesEuropean Journal of Biochemistry, 1997
- Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3Nature Genetics, 1996
- Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice.Molecular Biology of the Cell, 1995
- Role of Heparan Sulfate in the Terminal Differentiation of Growth Plate ChondrocytesArchives of Biochemistry and Biophysics, 1995
- Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesisCell, 1994
- Basic Fibroblast Growth Factor Binds to Heparan-Sulfate in the Extracellular Matrix of Rat Growth Plate ChondrocytesArchives of Biochemistry and Biophysics, 1994